ArticleCureus2025
A Single-Center Review of Renal Replacement Therapy in Patients With Acute Traumatic Brain Injury.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraumatic brain injury (TBI) is a major cause of morbidity, and concomitant acute kidney injury presents substantial management challenges. Continuous renal replacement therapy (CRRT) is thought to cause less hemodynamic instability than intermittent hemodialysis (IHD) after TBI, but factors associated with modality selection in TBI remain unclear. We sought to describe the clinical characteristics and outcomes of patients with TBI requiring renal replacement therapy and to test whether injury severity, Glasgow Coma Scale (GCS), and comorbidity burden were associated with the receipt of CRRT vs. IHD.
methodsThis 10-year retrospective study at a level I trauma center included adult TBI patients requiring renal replacement therapy. Patients were grouped by modality (CRRT vs. IHD), and demographics, injury severity, and outcome variables were compared.
resultsEighty-one patients met the inclusion criteria; 52 received IHD and 29 received CRRT. Patients receiving IHD were older (69 vs. 58 years, p=0.006) and had higher Charlson Comorbidity Index scores (6.6 vs. 3.5, p<0.001). Patients receiving CRRT had lower presenting GCS (8.7 vs. 13.5, p<0.001) and higher injury severity scores (24.5 vs. 16.2, p=0.006). CRRT patients had higher mortality (62.1% vs. 30.8%, p<0.001), longer hospital stays (17 vs. 8.6 days, p=0.001), and were more commonly discharged with severe disability (17.2% vs. 3.8%, p=0.001).
conclusionIn this retrospective cohort, we found that CRRT was more frequently used in TBI patients with worse injuries and lower levels of consciousness on presentation, whereas patients with greater comorbid burden were more likely to receive IHD. These findings highlight the need for evidence-based guidelines to inform renal replacement modality selection in acute TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.